Hualan Bioengineering Co., Ltd. Hualan Bioengineering Co., Ltd. (formerly known as Hualan Bioengineering Co., Ltd.) was established in 1992. It is a national key high-tech enterprise engaged in the research and development and production of blood products, and passed the GMP certification of blood products industry for the first time in 1998.
State-owned enterprises refer to wholly state-owned enterprises, wholly state-owned companies and state-owned capital holding companies that the State Council and local people's governments perform the responsibilities of investors on behalf of the country respectively, including enterprises at the same level and enterprises formed by investment step by step under the supervision of central and local state-owned assets supervision and administration institutions and other departments.
Extended data:
I. Company Profile
Hualan bioengineering Co., Ltd., formerly known as Hualan bioengineering Co., Ltd., was established in 1992. It is a national key high-tech enterprise engaged in the research and development and production of blood products, and passed the GMP certification of blood products industry for the first time in 1998. ?
As a national designated large-scale biological product manufacturer, the company has undertaken a number of national, provincial and municipal scientific and technological research projects, among which freeze-dried human fibrin glue for surgery has been included in the national 863 project.
The establishment of Hualan Postdoctoral Research Center and the listing of Henan Biomedical Engineering Technology Center have laid a solid foundation for the high growth and core competitiveness of enterprises.
Second, the company's contribution
After years of hard work, the company's vaccine business has established a product echelon, which has contributed more to the company's performance than blood products within 3 to 5 years. Albumin is widely used in vaccine production. The integrated product structure and complete variety echelon make the company have cost advantage and scale effect compared with neonatal vaccine enterprises.
Compared with domestic traditional advantage vaccine enterprises, it has strong institutional flexibility and late-comer advantage, and a new generation of vaccine leader is ready to emerge.
Affected by the new epidemic situation of influenza A (H 1N 1), the company has accelerated the review process of influenza vaccine, and it is expected to submit a production application in a few months. It is expected to become the second national strategic reserve influenza vaccine supplier after Jingkexing, and its products can be put into the market when a large-scale epidemic breaks out.
In 2008, the number of influenza vaccines issued in batches ranked first among domestic enterprises, and the dosage forms for children have also been approved for clinical use. We have signed an agreement with SK Chemical Company, the largest influenza vaccine supplier in Korea, and started to enter the international market.
Baidu Encyclopedia-Hualan Biology
Baidu encyclopedia-state-owned enterprise